Addus HomeCare Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0067391062
USD
105.60
-10.96 (-9.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Addus HomeCare Corp. stock-summary
stock-summary
Addus HomeCare Corp.
Pharmaceuticals & Biotechnology
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company's personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living. The Company provides these non-medical services on a long-term, continuous basis. The Company delivers services to its consumers through 180 individual agencies located in 25 states. Its services, which include non-medical care, such as personal care services, are provided to consumers who are unable to independently perform some or all of their activities of daily living.
Company Coordinates stock-summary
Company Details
6303 COWBOYS WAY, SUITE 600 , FRISCO TX : 75034
stock-summary
Tel: 1 469 53582001 630 2963400
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 94 Schemes (49.84%)

Foreign Institutions

Held by 124 Foreign Institutions (7.47%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Steven Geringer
Independent Chairman of the Board
Mr. R. Dirk Allison
President, Chief Executive Officer, Director
Mr. Michael Earley
Independent Director
Mr. Mark First
Independent Director
Mr. Darin Gordon
Independent Director
Ms. Veronica Hill-Milbourne
Independent Director
Dr. Esteban Lopez
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
349 Million
(Quarterly Results - Jun 2025)
Net Profit:
22 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,020 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

9.35%

stock-summary
Price to Book

1.92